The European School of Oncology discusses upcoming AI-driven innovations in cancer treatment, focusing on novel drug developments. The role of AI is emphasized in personalizing therapies and predicting treatment responses across Europe and globally, showcasing tools that enhance precision medicine capabilities and improve patient outcomes.

Read More:

• 🔗 oncodaily.com